Press Releases

SAN DIEGO, May 6, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutical class action lawsuit charges West Pharmaceutical and certain of West Pharmaceutical's current and former top executives with violations of the Securities Exchange Act of 1934.

Rsum de l'actualit

LEXINGTON, Mass., May 6, 2025 /PRNewswire/ --Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved the grant of inducement stock options to its newly appointed Chief Medical Officer, Dr. Ahmed Hamdy to purchase 200,000 shares of Curis common stock, with a grant date of May 1, 2025 (the "Inducement Grant").

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery. Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the superpotent corticosteroid, clobetasol propionate, and is derived from Formosa Pharma's proprietary APNT nanoparticle formulation platform. The novel formulation enables a convenient and straightforward dosing regimen, while providing rapid and sustained relief of inflammation and pain, which in Phase 3 trials proved statistically and clinically superior to its matching placebo (p<0.001).

WASHINGTON, May 6, 2025 /PRNewswire/ -- The Independence Fund, a national non-profit organization dedicated to serving the needs of catastrophically wounded Veterans and their families, was honored to join six of our nation's Veterans at today's Senate Committee on Veterans' Affairs hearing, "Veterans at the Forefront: Secretary Collins on the Future at VA."

SAN DIEGO, May 6, 2025 /PRNewswire/ -- Adcentrx Therapeutics("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program, ADRX-0706, for the treatment of patients with locally advanced or metastatic squamous cell cervical cancer.

CHICAGO, May 6, 2025 /PRNewswire/ -- Veltex Corporation (OTCQB: VLXC), a premier Health and Wellness Acquisition Firm, is pleased to announce key enhancements to its leadership structure as part of its continued growth strategy and mission to serve communities impacted by substance use disorder.

LOS ANGELES, May 6, 2025 /PRNewswire/ -- Dr. Austin Harris, Dr. Austin Harris, MD, founder of NeuroRelief Ketamine & Infusion Therapy, offers a $1,000 grant to support student athletes balancing academics and sports. This scholarship is open to undergraduates at accredited U.S. colleges who show dedication both on the field and in the classroom.

CHICO, Calif., May 6, 2025 /PRNewswire/ -- Dr. ZacharyLipman, a dedicated physician and advocate for well-being, is pleased to announce the establishment of the Dr. Zachary Lipman Scholarship for Student Athletes. This one-time award of $1,000 aims to provide financial assistance to undergraduate students who actively participate in athletics and demonstrate a clear intention to pursue a career within the sports field.

SUZHOU, China, May 6, 2025 /PRNewswire/ --CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC), key assets in CStone Pipeline 2.0, have been delivered at the 2025 American Association for Cancer Research (AACR) Annual Meeting.

LOS ANGELES, May 6, 2025 /PRNewswire/ --May isALS Awareness Month, and the ALS Network is committed to raising awareness and understanding of the devastating disease that has no known cure. This month, we highlight the power of community and invite everyone to explore the many ways to get involved, give back, and learn more.

FLORHAM PARK, N.J., May 6, 2025 /PRNewswire/ -- Datacor, Inc., a leading provider of process manufacturing, engineering, and chemical distribution software, announces the acquisition of Baytek International, a provider of Laboratory Information Management Systems (LIMS) and Quality Control (QC) software. This acquisition expands Datacor's capabilities, allowing customers to further enhance their regulatory compliance, quality assurance, and laboratory management processes.

WASHINGTON, May 6, 2025 /PRNewswire/ -- The Fermi Gamma-ray Burst Monitor (GBM) Collaboration, which includes a team at Universities Space Research Association's Science and Technology Institute, has been awarded the 2025 Giuseppe and Vanna Cocconi Prize by the European Physical Society (EPS). The prize recognizes the team's pioneering contributions to multimessenger astrophysics. The prize was also awarded to the Fermi Large Area Telescope (LAT Collaboration) for its achievements in gamma-ray astronomy.

MAUMEE, Ohio, May 6, 2025 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces financial results for the first quarter ended March31, 2025.

SCOTTSDALE, Ariz., May 6, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, today announced financial results for the first quarter ended March 29, 2025.

DALLAS, May 6, 2025 /PRNewswire/ --Mike Hsu, Chairman and CEO of Kimberly-Clark Corporation (NYSE: KMB) and Nelson Urdaneta, Chief Financial Officer, will be featured speakers at the Goldman Sachs Global Staples Forum on Tuesday, May 13, at 9:35 a.m. ET.

BEVERLY HILLS, Calif., May 6, 2025 /PRNewswire/ -- TheArman Gabaee Real Estate Scholarship is now open for applications, offering undergraduate students across the United States an opportunity to gain financial support as they pursue careers in the dynamic and technology-driven real estate industry. The scholarship reflects Arman Gabaee's enduring commitment to fostering academic growth, industry innovation, and socially responsible development.

TOKYO, May 7, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint research* with RIBOMIC Inc. (President: Yoshikazu Nakamura, Headquarters: Minato-ku, Tokyo, hereinafter referred to as "RIBOMIC"), a drug discovery startup focused on the development and production of aptamer pharmaceuticals, on the development of technology for controlling the pharmacokinetics of nucleic acid aptamers using the antibody-drug conjugate (ADC) manufacturing technology "AJICAP" (hereinafter referred to as "AJICAP"). As a result of this research, RIBOMIC has successfully extended the half-life of a conjugate of nucleic acid aptamers and the Fc region of immunoglobulins in the bloodstream.

TOKYO, May 6, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint research* with RIBOMIC Inc. (President: Yoshikazu Nakamura, Headquarters: Minato-ku, Tokyo, hereinafter referred to as "RIBOMIC"), a drug discovery startup focused on the development and production of aptamer pharmaceuticals, on the development of technology for controlling the pharmacokinetics of nucleic acid aptamers using the antibody-drug conjugate (ADC) manufacturing technology "AJICAP" (hereinafter referred to as "AJICAP"). As a result of this research, RIBOMIC has successfully extended the half-life of a conjugate of nucleic acid aptamers and the Fc region of immunoglobulins in the bloodstream.

SHANGHAI, May 6, 2025 /PRNewswire/ -- At the Auto Shanghai 2025, HIGHLY (Shanghai Highly Group Co., Ltd.), a global leader in new energy vehicle (NEV) thermal management systems, unveiled its breakthrough lightweight, integrated solutions tailored for next-generation electric vehicles. The highlights include the R290 Refrigerant Thermal Management Module,Low-Temperature Heat Pump Self-Heating Compressor, andLow-Temperature Heat Pump Integrated Compressor, reinforcing HIGHLY's technological leadership in eco-friendly, high-efficiency automotive thermal management.

BUDAPEST, Hongrie, 7 mai 2025 /PRNewswire/ -- Un centre offrant un soutien mdical et ducatif ainsi qu'un abri aux femmes vulnrables a t construit Bamako, la capitale du Mali, grce l'aide financire de Gedeon Richter. En tant que l'un des principaux fabricants mondiaux de mdicaments pour la sant des femmes, Richter souligne l'importance de promouvoir la sant et la qualit de vie des femmes dans tous les pays o il opre. Avec ce nouveau centre, en mesure d'accueillir des dizaines de femmes dfavorises de la rgion, Richter a pour objectif de venir en aide prs de 300 femmes par an. Cette initiative n'est pas un simple investissement ponctuel, car l'entreprise pharmaceutique s'est engage soutenir long terme le fonctionnement de la Maison de l'Espoir.

BUDAPEST, Hungra, 7 de mayo de 2025 /PRNewswire/ -- En Bamako, capital de Mali, se ha construido un centro que ofrece atencin mdica, apoyo educativo y albergue para mujeres vulnerables, con la ayuda financiera de Gedeon Richter. Como uno de los principales fabricantes mundiales de medicamentos para la salud femenina, Richter enfatiza la importancia de promover la salud y la calidad de vida de las mujeres en todos los pases donde opera. Con el nuevo centro, capaz de albergar a decenas de mujeres desfavorecidas de la regin, Richter aspira a brindar ayuda a casi 300 mujeres al ao. Esta iniciativa no es una inversin puntual, ya que la compaa farmacutica se compromete a apoyar a largo plazo el funcionamiento del centro House of Hope.

LOS ANGELES, May 6, 2025 /PRNewswire/ -- At the 2025 Advanced Clean Transportation (ACT) Expo, Winline Technology, a global provider of electric vehicle charging modules and intelligent energy systems, showcased a suite of high-efficiency, high-reliability power modules designed to meet the surging demand in the North American EV and charging infrastructure markets. Throughout the event, Winline Technology engaged in dynamic discussions with industry experts, partners, and potential clients, emphasizing the innovative features of its products and their pivotal role in addressing the challenges of an evolving EV infrastructure. The booth attracted significant attention, with many attendees expressing keen interest in Winline Technology's advanced solutions for EV charging and grid resilience.

Co-Founder and longtime Chief Executive Officer Trevor Hardy to retire; BlueWave welcomes Sean Finnerty, accomplished executive with more than 25 years of renewable energy development and operations experience

MUNICH, May 6, 2025 /PRNewswire/ --The global textile industry is one of the most environmentally damaging supply chains, contributing up to 8% of global CO emissions, according to the United Nations Environment Programme(UNEP). The textile value chain alone is projected to generate 2.7 billion tons of CO annually by 2030, equivalent to emissions from nearly 230 million passenger vehicles per year. US scientists Neeka and Leila Mashouf (28) co-founded Rubi, a startup focusing on manufacturing with technology that transforms waste carbon into essential materials, including textiles. Their breakthrough has earned them a place as one of ten global innovators, in the Young Inventors Prize known as Tomorrow Shapers, 2025. They have been selected from 450 candidates by an independent jury.